Literature DB >> 16888766

The discovery of labile methyl esters on proliferating cell nuclear antigen by MS/MS.

Derek J Hoelz1, Randy J Arnold, Lacey E Dobrolecki, Waleed Abdel-Aziz, Andrew P Loehrer, Milos V Novotny, Lauren Schnaper, Robert J Hickey, Linda H Malkas.   

Abstract

The post-translational modification of proliferating cell nuclear antigen (PCNA) has been implicated in modulating its function for over 20 years. With multiple interacting partners, PCNA is involved in processes ranging from DNA replication and repair to cell cycle control and apoptosis. The ability of PCNA to distinguish between specific binding partners in different tasks is currently of intense interest, and several post-translational modifications have been reported to modulate its function. Unfortunately, these reports have produced contradictory information on the type(s) of modification present on the molecule. Here we report a detailed structural analysis of a single acidic PCNA isoform, cancer-specific polyferating nuclear anitgen (csPCNA), isolated from breast cancer cells by 2D-PAGE and LC-MS/MS. With this approach we fully characterized the csPCNA isoform and confidently identified a single post-translational modification, methyl esterification. Interestingly, the methyl esters consistently localized to 15 specific glutamic and aspartic acid residues of csPCNA. The methyl esterification of csPCNA represents a novel type of post-translational modification in mammalian cells that could ultimately hold the key towards unlocking its diverse functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16888766     DOI: 10.1002/pmic.200600142

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  21 in total

1.  Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.

Authors:  Xiaoyan Wang; Robert J Hickey; Linda H Malkas; Michael O Koch; Lang Li; Shaobo Zhang; George E Sandusky; David J Grignon; John N Eble; Liang Cheng
Journal:  Prostate       Date:  2010-10-28       Impact factor: 4.104

2.  Human C6orf211 encodes Armt1, a protein carboxyl methyltransferase that targets PCNA and is linked to the DNA damage response.

Authors:  J Jefferson P Perry; Gregory D Ballard; Alexandra E Albert; Lacey E Dobrolecki; Linda H Malkas; Derek J Hoelz
Journal:  Cell Rep       Date:  2015-02-26       Impact factor: 9.423

Review 3.  Nuclear protein isoforms: implications for cancer diagnosis and therapy.

Authors:  Fei Shen; Kashif Z Kirmani; Zhimin Xiao; Benjamin H Thirlby; Robert J Hickey; Linda H Malkas
Journal:  J Cell Biochem       Date:  2011-03       Impact factor: 4.429

4.  A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker.

Authors:  Linda H Malkas; Brittney Shea Herbert; Waleed Abdel-Aziz; Lacey E Dobrolecki; Yang Liu; Beamon Agarwal; Derek Hoelz; Sunil Badve; Lauren Schnaper; Randy J Arnold; Yehia Mechref; Milos V Novotny; Patrick Loehrer; Robert J Goulet; Robert J Hickey
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-11       Impact factor: 11.205

5.  A Peptide mimicking a region in proliferating cell nuclear antigen specific to key protein interactions is cytotoxic to breast cancer.

Authors:  Shanna J Smith; Long Gu; Elizabeth A Phipps; Lacey E Dobrolecki; Karla S Mabrey; Pattie Gulley; Kelsey L Dillehay; Zhongyun Dong; Gregg B Fields; Yun-Ru Chen; David Ann; Robert J Hickey; Linda H Malkas
Journal:  Mol Pharmacol       Date:  2014-12-05       Impact factor: 4.436

6.  Validating the disruption of proliferating cell nuclear antigen interactions in the development of targeted cancer therapeutics.

Authors:  Shanna J Smith; Robert J Hickey; Linda H Malkas
Journal:  Cancer Biol Ther       Date:  2016-02-18       Impact factor: 4.742

Review 7.  The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma.

Authors:  Shuangshuang Ma; Junsheng Yang; Jinpeng Li; Jinlong Song
Journal:  Tumour Biol       Date:  2015-12-17

8.  Complications in the assignment of 14 and 28 Da mass shift detected by mass spectrometry as in vivo methylation from endogenous proteins.

Authors:  Sung Yun Jung; Yehua Li; Yi Wang; Yue Chen; Yingming Zhao; Jun Qin
Journal:  Anal Chem       Date:  2008-02-05       Impact factor: 6.986

9.  The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA.

Authors:  Long Gu; Robert Lingeman; Fumiko Yakushijin; Emily Sun; Qi Cui; Jianfei Chao; Weidong Hu; Hongzhi Li; Robert J Hickey; Jeremy M Stark; Yate-Ching Yuan; Yuan Chen; Steven L Vonderfecht; Timothy W Synold; Yanhong Shi; Karen L Reckamp; David Horne; Linda H Malkas
Journal:  Clin Cancer Res       Date:  2018-07-02       Impact factor: 12.531

10.  Identification of X-DING-CD4, a new member of human DING protein family that is secreted by HIV-1 resistant CD4(+) T cells and has anti-viral activity.

Authors:  Adam Lesner; Rasheda Shilpi; Anna Ivanova; Mary Ann Gawinowicz; Jacob Lesniak; Dimitar Nikolov; Malgorzata Simm
Journal:  Biochem Biophys Res Commun       Date:  2009-08-29       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.